Alnylam Pharmaceuticals, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Jul 3010-QQuarterly report
- Jul 308-KResults of operations2.029.01
- May 278-KOfficer or director change and shareholder vote5.025.07
- Apr 3010-QQuarterly report
- Apr 308-KResults of operations2.029.01
- Mar 48-KOfficer or director change5.02
- Feb 1210-KAnnual report
- Feb 128-KResults of operations2.029.01
- Jan 128-KResults of operations2.02
- Dec 11, 20258-KOther events8.019.01
- Dec 3, 20258-KOfficer or director change5.02
- Oct 30, 202510-QQuarterly report
- Oct 30, 20258-KResults of operations2.029.01
- Oct 3, 20258-KMaterial agreement and new debt or obligation1.012.039.01
- Sep 12, 20258-KMaterial agreement and unregistered sale of shares1.012.033.028.019.01
- Sep 10, 20258-KOther events8.019.01
- Jul 31, 202510-QQuarterly report
- Jul 31, 20258-KResults of operations2.029.01
- Jun 18, 20258-KOfficer or director change5.02